75 related articles for article (PubMed ID: 7521151)
1. Interferon entry through the blood-brain barrier in glioma and its effect on lipoxygenase activity.
Wiranowska M; Prockop LD; Naidu AK; Saporta S; Kori S; Kulkarni AP
Anticancer Res; 1994; 14(3A):1121-6. PubMed ID: 7521151
[TBL] [Abstract][Full Text] [Related]
2. Modulation of glioma cell growth and 5-lipoxygenase expression by interferon.
Naidu KA; Wiranowska M; Phuphanich S; Prockop LD
Anticancer Res; 1996; 16(6B):3475-82. PubMed ID: 9042209
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of blood-brain barrier permeability and the effect of interferon in mouse glioma model.
Wiranowska M; Gonzalvo AA; Saporta S; Gonzalez OR; Prockop LD
J Neurooncol; 1992 Nov; 14(3):225-36. PubMed ID: 1281226
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing.
Pace JL; Russell SW; LeBlanc PA; Murasko DM
J Immunol; 1985 Feb; 134(2):977-81. PubMed ID: 2578167
[TBL] [Abstract][Full Text] [Related]
5. CD44 expression and MMP-2 secretion by mouse glioma cells: effect of interferon and anti-CD44 antibody.
Wiranowska M; Rojiani AM; Gottschall PE; Moscinski LC; Johnson J; Saporta S
Anticancer Res; 2000; 20(6B):4301-6. PubMed ID: 11205262
[TBL] [Abstract][Full Text] [Related]
6. In vivo myelosuppression by combination interferon treatment: antagonism of MuIFN-gamma and MuIFN-beta myelosuppressive effects.
Naldini A; Fleischmann WR
J Biol Response Mod; 1987 Oct; 6(5):546-55. PubMed ID: 3119781
[TBL] [Abstract][Full Text] [Related]
7. [Effect of interferon on mouse glioma].
Nakagawa Y; Suzuki K; Ibayashi N; Ueda S; Hirakawa K; Oku T; Imanishi J; Kishida T
No To Shinkei; 1983 Nov; 35(11):1125-30. PubMed ID: 6197981
[TBL] [Abstract][Full Text] [Related]
8. Differential antiproliferative activities of IFNs alpha, beta and gamma: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs alpha and beta.
Fleischmann CM; Fleischmann WR
J Biol Regul Homeost Agents; 1988; 2(4):173-85. PubMed ID: 3150645
[TBL] [Abstract][Full Text] [Related]
9. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
10. Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood-brain barrier.
Borlongan CV; Lind JG; Dillon-Carter O; Yu G; Hadman M; Cheng C; Carroll J; Hess DC
Brain Res; 2004 May; 1009(1-2):26-33. PubMed ID: 15120580
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse.
Natsume A; Mizuno M; Ryuke Y; Yoshida J
Gene Ther; 1999 Sep; 6(9):1626-33. PubMed ID: 10490773
[TBL] [Abstract][Full Text] [Related]
12. RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
Tjuvajev J; Gansbacher B; Desai R; Beattie B; Kaplitt M; Matei C; Koutcher J; Gilboa E; Blasberg R
Cancer Res; 1995 May; 55(9):1902-10. PubMed ID: 7728757
[TBL] [Abstract][Full Text] [Related]
13. Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma.
Kanno H; Hattori S; Sato H; Murata H; Huang FH; Hayashi A; Suzuki N; Yamamoto I; Kawamoto S; Minami M; Miyatake S; Shuin T; Kaplitt MG
Cancer Gene Ther; 1999; 6(2):147-54. PubMed ID: 10195881
[TBL] [Abstract][Full Text] [Related]
14. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
15. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
16. Prevention of resistance to IFN-alpha antiproliferative activity: characterization of the effect of IFN-gamma and substitution for IFN-gamma by tumor necrosis factor.
Fleischmann CM; Stanton GJ; Fleischmann WR
J Biol Regul Homeost Agents; 1993; 7(2):50-7. PubMed ID: 8266815
[TBL] [Abstract][Full Text] [Related]
17. The effect of interferon and anti-CD44 antibody on mouse glioma invasiveness in vitro.
Wiranowska M; Tresser N; Saporta S
Anticancer Res; 1998; 18(5A):3331-8. PubMed ID: 9858905
[TBL] [Abstract][Full Text] [Related]
18. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
[TBL] [Abstract][Full Text] [Related]
20. Characterization of murine interferon-alpha 12 (MuIFN-alpha12): biological activities and gene expression.
Tsang SL; Leung PC; Leung KK; Yau WL; Hardy MP; Mak NK; Leung KN; Fung MC
Cytokine; 2007 Feb; 37(2):138-49. PubMed ID: 17451966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
